{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:40:22Z","timestamp":1791049222072,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["1R01EY026609-01"],"award-info":[{"award-number":["1R01EY026609-01"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cincinnati Children\u2019s Hospital Research Foundation"},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R24 OD021325-01"],"award-info":[{"award-number":["R24 OD021325-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005946","name":"The Jackson Laboratory","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005946","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s10038-018-0515-y","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T02:48:30Z","timestamp":1537843710000},"page":"1211-1222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Biallelic mutations in FDXR cause neurodegeneration associated with inflammation"],"prefix":"10.1038","volume":"63","author":[{"given":"Jesse","family":"Slone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Chamberlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Kaylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie T.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Lemmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mays Antonine","family":"El-Dairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Tchapyjnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A","family":"Gonzalez-Krellwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Sellars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyn","family":"McConkie-Rosell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura G.","family":"Reinholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taosheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"515_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0092-8674(90)90059-N","volume":"61","author":"JM Shoffner","year":"1990","unstructured":"Shoffner JM, Lott MT, AMS Lezza, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell. 1990;61:931\u20137.","journal-title":"Cell"},{"key":"515_CR2","doi-asserted-by":"publisher","first-page":"6755","DOI":"10.1074\/jbc.M008114200","volume":"276","author":"LG Nijtmans","year":"2001","unstructured":"Nijtmans LG, Henderson NS, Attardi G, Holt IJ. Impaired ATP synthase assembly associated with a mutation in the human ATP synthase subunit 6 gene. J Biol Chem. 2001;276:6755\u201362.","journal-title":"J Biol Chem"},{"key":"515_CR3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/348651a0","volume":"348","author":"Y Goto","year":"1990","unstructured":"Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990;348:651\u20133.","journal-title":"Nature"},{"key":"515_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev.genet.39.110304.095751","volume":"39","author":"DC Wallace","year":"2005","unstructured":"Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005;39:359\u2013407.","journal-title":"Annu Rev Genet"},{"key":"515_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6013","volume":"5","author":"H Webert","year":"2014","unstructured":"Webert H, Freibert SA, Gallo A, Heidenreich T, Linne U, Amlacher S, et al. Functional reconstitution of mitochondrial Fe\/S cluster synthesis on Isu1 reveals the involvement of ferredoxin. Nat Commun. 2014;5:5013.","journal-title":"Nat Commun"},{"key":"515_CR6","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.bbamcr.2014.12.018","volume":"1853","author":"VD Paul","year":"2015","unstructured":"Paul VD, Lill R. Biogenesis of cytosolic and nuclear iron-sulfur proteins and their role in genome stability. Biochim Biophys Acta. 2015;1853:1528\u201339.","journal-title":"Biochim Biophys Acta"},{"key":"515_CR7","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.1093\/hmg\/ddt295","volume":"22","author":"SC Lim","year":"2013","unstructured":"Lim SC, Friemel M, Marum JE, Tucker EJ, Bruno DL, Riley LG, et al. Mutations in LYRM4, encoding iron-sulfur cluster biogenesis factor ISD11, cause deficiency of multiple respiratory chain complexes. Hum Mol Genet. 2013;22:4460\u201373.","journal-title":"Hum Mol Genet"},{"key":"515_CR8","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ajhg.2009.04.004","volume":"84","author":"A Di Fonzo","year":"2009","unstructured":"Di Fonzo A, Ronchi D, Lodi T, Fassone E, Tigano M, Lamperti C, et al. The mitochondrial disulfide relay system protein GFER is mutated in autosomal-recessive myopathy with cataract and combined respiratory-chain deficiency. Am J Hum Genet. 2009;84:594\u2013604.","journal-title":"Am J Hum Genet"},{"key":"515_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fphar.2014.00130","volume":"5","author":"A Martelli","year":"2014","unstructured":"Martelli A, Puccio H. Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation. Front Pharmacol. 2014;5:130.","journal-title":"Front Pharmacol"},{"key":"515_CR10","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1093\/hmg\/ddx377","volume":"26","author":"Y Peng","year":"2017","unstructured":"Peng Y, Shinde DN, Valencia CA, Mo JS, Rosenfeld J, Truitt Cho M, et al. Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy. Hum Mol Genet. 2017;26:4937\u201350.","journal-title":"Hum Mol Genet"},{"key":"515_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ajhg.2017.09.007","volume":"101","author":"A Paul","year":"2017","unstructured":"Paul A, Drecourt A, Petit F, Deguine DD, Vasnier C, Oufadem M, et al. FDXR mutations cause sensorial neuropathies and expand the spectrum of mitochondrial Fe-S-synthesis diseases. Am J Hum Genet. 2017;101:630\u20137.","journal-title":"Am J Hum Genet"},{"key":"515_CR12","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/nm1001-1111","volume":"7","author":"PM Hwang","year":"2001","unstructured":"Hwang PM, Bunz F, Yu J, Rago C, Chan TA, Murphy MP, et al. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med. 2001;7:1111\u20137.","journal-title":"Nat Med"},{"key":"515_CR13","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.1073\/pnas.85.19.7104","volume":"85","author":"SB Solish","year":"1988","unstructured":"Solish SB, Picado-Leonard J, Morel Y, Kuhn RW, Mohandas TK, Hanukoglu I, et al. Human adrenodoxin reductase: two mRNAs encoded by a single gene on chromosome 17cen----q25 are expressed in steroidogenic tissues. Proc Natl Acad Sci USA. 1988;85:7104\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"515_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.bbamcr.2011.11.002","volume":"1823","author":"Y Shi","year":"2012","unstructured":"Shi Y, Ghosh M, Kovtunovych G, Crooks DR, Rouault TA. Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis. Biochim Biophys Acta. 2012;1823:484\u201392.","journal-title":"Biochim Biophys Acta"},{"key":"515_CR15","doi-asserted-by":"publisher","first-page":"11775","DOI":"10.1073\/pnas.1004250107","volume":"107","author":"AD Sheftel","year":"2010","unstructured":"Sheftel AD, Stehling O, Pierik AJ, Elsasser HP, Muhlenhoff U, Webert H, et al. Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe\/S cluster biosynthesis. Proc Natl Acad Sci USA. 2010;107:11775\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"515_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1021\/acs.biochem.6b00447","volume":"56","author":"K Cai","year":"2017","unstructured":"Cai K, Tonelli M, Frederick RO, Markley JL. Human mitochondrial ferredoxin 1 (FDX1) and ferredoxin 2 (FDX2) both bind cysteine desulfurase and donate electrons for iron-sulfur cluster biosynthesis. Biochemistry. 2017;56:487\u201399.","journal-title":"Biochemistry"},{"key":"515_CR17","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1016\/S0021-9258(19)85851-9","volume":"255","author":"I Hanukoglu","year":"1980","unstructured":"Hanukoglu I, Jefcoate CR. Mitochondrial cytochrome P-450scc. Mechanism of electron transport by adrenodoxin. J Biol Chem. 1980;255:3057\u201361.","journal-title":"J Biol Chem"},{"key":"515_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138:103\u201341.","journal-title":"Pharmacol Ther"},{"key":"515_CR19","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/0960-0760(92)90307-5","volume":"43","author":"I Hanukoglu","year":"1992","unstructured":"Hanukoglu I. Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis. J Steroid Biochem Mol Biol. 1992;43:779\u2013804.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"515_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ajhg.2015.07.014","volume":"97","author":"AJ Tanaka","year":"2015","unstructured":"Tanaka AJ, Cho MT, Millan F, Juusola J, Retterer K, Joshi C, et al. Mutations in SPATA5 are associated with microcephaly, intellectual disability, seizures, and hearing loss. Am J Hum Genet. 2015;97:457\u201364.","journal-title":"Am J Hum Genet"},{"key":"515_CR21","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1093\/hmg\/ddx262","volume":"26","author":"Z Li","year":"2017","unstructured":"Li Z, Peng Y, Hufnagel RB, Hu YC, Zhao C, Queme LF, et al. Loss of SLC25A46 causes neurodegeneration by affecting mitochondrial dynamics and energy production in mice. Hum Mol Genet. 2017;26:3776\u201391.","journal-title":"Hum Mol Genet"},{"key":"515_CR22","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1101\/gr.186882.114","volume":"25","author":"H Fairfield","year":"2015","unstructured":"Fairfield H, Srivastava A, Ananda G, Liu R, Kircher M, Lakshminarayana A, et al. Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. Genome Res. 2015;25:948\u201357.","journal-title":"Genome Res"},{"key":"515_CR23","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, et al. Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271:1423\u20137.","journal-title":"Science"},{"key":"515_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ng1097-215","volume":"17","author":"A Rotig","year":"1997","unstructured":"Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997;17:215\u20137.","journal-title":"Nat Genet"},{"key":"515_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/hmg\/11.3.217","volume":"11","author":"P Cavadini","year":"2002","unstructured":"Cavadini P, O\u2019Neill HA, Benada O, Isaya G. Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia. Hum Mol Genet. 2002;11:217\u201327.","journal-title":"Hum Mol Genet"},{"key":"515_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nicl.2014.08.018","volume":"6","author":"K Solbach","year":"2014","unstructured":"Solbach K, Kraff O, Minnerop M, Beck A, Sch\u00f6ls L, Gizewski ER, et al. Cerebellar pathology in Friedreich\u2019s ataxia: Atrophied dentate nuclei with normal iron content. NeuroImage Clin. 2014;6:93\u20139.","journal-title":"NeuroImage Clin"},{"key":"515_CR27","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","volume":"68","author":"AE Oakley","year":"2007","unstructured":"Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, et al. Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology. 2007;68:1820\u20135.","journal-title":"Neurology"},{"key":"515_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/ars.2013.5593","volume":"21","author":"D Devos","year":"2014","unstructured":"Devos D, Moreau C, Devedjian JC, Kluza J, Petrault M, Laloux C, et al. Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease. Antioxid Redox Signal. 2014;21:195\u2013210.","journal-title":"Antioxid Redox Signal"},{"key":"515_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01402-2","volume":"7","author":"A Martin-Bastida","year":"2017","unstructured":"Martin-Bastida A, Ward RJ, Newbould R, Piccini P, Sharp D, Kabba C, et al. Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson\u2019s disease. Sci Rep. 2017;7:1398.","journal-title":"Sci Rep"},{"key":"515_CR30","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3324\/haematol.2011.043018","volume":"96","author":"G Abbruzzese","year":"2011","unstructured":"Abbruzzese G, Cossu G, Balocco M, Marchese R, Murgia D, Melis M, et al. A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica. 2011;96:1708\u201311.","journal-title":"Haematologica"},{"key":"515_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12311-010-0212-7","volume":"10","author":"D Velasco-Sanchez","year":"2011","unstructured":"Velasco-Sanchez D, Aracil A, Montero R, Mas A, Jimenez L, O\u2019Callaghan M, et al. Combined therapy with idebenone and deferiprone in patients with Friedreich\u2019s ataxia. Cerebellum. 2011;10:1\u20138.","journal-title":"Cerebellum"},{"key":"515_CR32","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/ana.24248","volume":"76","author":"M Pandolfo","year":"2014","unstructured":"Pandolfo M, Arpa J, Delatycki MB, Le Quan Sang KH, Mariotti C, Munnich A, et al. Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial. Ann Neurol. 2014;76:509\u201321.","journal-title":"Ann Neurol"},{"key":"515_CR33","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1177\/0883073816636087","volume":"31","author":"S Elincx-Benizri","year":"2016","unstructured":"Elincx-Benizri S, Glik A, Merkel D, Arad M, Freimark D, Kozlova E, et al. Clinical experience with deferiprone treatment for friedreich ataxia. J Child Neurol. 2016;31:1036\u201340.","journal-title":"J Child Neurol"},{"key":"515_CR34","doi-asserted-by":"publisher","first-page":"D245","DOI":"10.1093\/nar\/gkm977","volume":"36","author":"N Hulo","year":"2008","unstructured":"Hulo N, Bairoch A, Bulliard V, Cerutti L, Cuche BA, de Castro E, et al. The 20 years of PROSITE. Nucleic Acids Res. 2008;36:D245\u2013D9.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-018-0515-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-018-0515-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-018-0515-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:06:36Z","timestamp":1684616796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-018-0515-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1038\/s10038-018-0515-y","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"assertion":[{"value":"1 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest. A.C. is a full-time employee of Ambry Genetics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}